Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release

Blood. 1999 Apr 1;93(7):2342-52.

Abstract

We have previously shown that nitric oxide (NO) stimulates apoptosis in different human neoplastic lymphoid cell lines through activation of caspases not only via CD95/CD95L interaction, but also independently of such death receptors. Here we investigated mitochondria-dependent mechanisms of NO-induced apoptosis in Jurkat leukemic cells. NO donor glycerol trinitrate (at the concentration, which induces apoptotic cell death) caused (1) a significant decrease in the concentration of cardiolipin, a major mitochondrial lipid; (2) a downregulation in respiratory chain complex activities; (3) a release of the mitochondrial protein cytochrome c into the cytosol; and (4) an activation of caspase-9 and caspase-3. These changes were accompanied by an increase in the number of cells with low mitochondrial transmembrane potential and with a high level of reactive oxygen species production. Higher resistance of the CD95-resistant Jurkat subclone (APO-R) cells to NO-mediated apoptosis correlated with the absence of cytochrome c release and with less alterations in other mitochondrial parameters. An inhibitor of lipid peroxidation, trolox, significantly suppressed NO-mediated apoptosis in APO-S Jurkat cells, whereas bongkrekic acid (BA), which blocks mitochondrial permeability transition, provided only a moderate antiapoptotic effect. Transfection of Jurkat cells with bcl-2 led to a complete block of apoptosis due to the prevention of changes in mitochondrial functions. We suggest that the mitochondrial damage (in particular, cardiolipin degradation and cytochrome c release) induced by NO in human leukemia cells plays a crucial role in the subsequent activation of caspase and apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Cardiolipins / metabolism
  • Caspase 3
  • Caspase 9
  • Caspases / metabolism
  • Chromans / pharmacology
  • Cytochrome c Group / metabolism*
  • Drug Resistance
  • Enzyme Activation / drug effects
  • Genes, bcl-2
  • Humans
  • Jurkat Cells / cytology
  • Jurkat Cells / drug effects
  • Jurkat Cells / metabolism
  • Lipid Peroxidation / drug effects
  • Lipolysis*
  • Membrane Lipids / metabolism
  • Mitochondria / metabolism*
  • Nitric Oxide / pharmacology*
  • Nitric Oxide Donors / pharmacology
  • Nitroglycerin / pharmacology
  • Oxidative Phosphorylation / drug effects
  • Proto-Oncogene Proteins c-bcl-2 / physiology
  • Reactive Oxygen Species
  • Recombinant Fusion Proteins / physiology
  • Stimulation, Chemical
  • Transfection
  • Tumor Cells, Cultured / drug effects

Substances

  • Cardiolipins
  • Chromans
  • Cytochrome c Group
  • Membrane Lipids
  • Nitric Oxide Donors
  • Proto-Oncogene Proteins c-bcl-2
  • Reactive Oxygen Species
  • Recombinant Fusion Proteins
  • Nitric Oxide
  • CASP3 protein, human
  • CASP9 protein, human
  • Caspase 3
  • Caspase 9
  • Caspases
  • Nitroglycerin
  • 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid